BioXcel Therapeutics Inc To Host Neuroscience R&D Day Transcript
Greetings, and welcome to the BioXcel Therapeutics Neuroscience R&D Day. At this time, I'd like to turn the call over to Dr. Frank Yocca of BioXcel. Thank you, you may begin.
Thank you, operator. Good afternoon, everyone. I'm Frank Yocca, Chief Science Officer at BioXcel Therapeutics. Thank you for joining our virtual Neuroscience R&D Day.
As a reminder, during today's presentation, we will be making forward-looking statements regarding our R&D plans. These statements are subject to risks and uncertainties that may cause actual results to materially differ from those forecast. The risk factors that may affect results are detailed in our most recent public filings with the SEC, including our most recent Form 10-Q on file with the SEC and available on our website.
Next slide, please.
It's been two years since we last hosted an R&D presentation for our neuroscience franchise emerging pipeline. And today we are very pleased to share with you several
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |